P. Vinnedge, L. M. Kappes, F. Nassar, N. Wells, and S. I. , Stacking the DEK: From chromatin topology to cancer stem cells, Cell Cycle, vol.12, issue.1, p.23255114, 2013.

T. Waldmann, M. Baack, N. Richter, and C. Gruss, Structure-specific binding of the proto-oncogene protein DEK to DNA, Nucleic Acids Res, vol.31, issue.23, p.290247, 2003.

T. Waldmann, C. Eckerich, M. Baack, and C. Gruss, The ubiquitous chromatin protein DEK alters the structure of DNA by introducing positive supercoils, J Biol Chem, vol.277, issue.28, p.11997399, 2002.

T. Waldmann, I. Scholten, F. Kappes, H. G. Hu, and R. Knippers, The DEK protein-an abundant and ubiquitous constituent of mammalian chromatin, Gene, vol.343, issue.1, p.15563827, 2004.

H. G. Hu, I. Scholten, C. Gruss, and R. Knippers, The distribution of the DEK protein in mammalian chromatin. Biochemical and biophysical research communications, vol.358, p.17524367, 2007.

A. K. Adams, L. C. Bolanos, P. J. Dexheimer, R. A. Karns, B. J. Aronow et al., IRAK1 is a novel DEK transcriptional target and is essential for head and neck cancer cell survival, Oncotarget, vol.6, issue.41, p.26527316, 2015.

Y. Zhang, J. Liu, S. Wang, X. Luo, Y. Li et al., The DEK oncogene activates VEGF expression and promotes tumor angiogenesis and growth in HIF-1alpha-dependent and-independent manners, Oncotarget, vol.7, issue.17, p.5029660, 2016.
DOI : 10.18632/oncotarget.8060

URL : http://www.impactjournals.com/oncotarget/index.php?journal=oncotarget&page=article&op=view&path%5B%5D=8060&path%5B%5D=24193

M. Sammons, S. S. Wan, N. L. Vogel, E. J. Mientjes, G. Grosveld et al., Negative regulation of the RelA/p65 transactivation function by the product of the DEK proto-oncogene, J Biol Chem, vol.281, issue.37, p.16829531, 2006.

D. W. Kim, J. Y. Kim, S. Choi, S. Rhee, Y. Hahn et al., Transcriptional regulation of 1-cys peroxiredoxin by the proto-oncogene protein DEK, Molecular medicine reports, vol.3, issue.5, p.21472329, 2010.

D. W. Kim, J. I. Chae, J. Y. Kim, J. H. Pak, D. B. Koo et al., Proteomic analysis of apoptosis related proteins regulated by proto-oncogene protein DEK, Journal of cellular biochemistry, vol.106, issue.6, 2009.
DOI : 10.1002/jcb.22083

G. M. Kavanaugh, T. M. Wise-draper, R. J. Morreale, M. A. Morrison, B. Gole et al., The human DEK oncogene regulates DNA damage response signaling and repair, Nucleic Acids Res, vol.39, 2011.
DOI : 10.1093/nar/gkr454

URL : https://academic.oup.com/nar/article-pdf/39/17/7465/16777557/gkr454.pdf

M. Karam, M. Thenoz, V. Capraro, J. P. Robin, C. Pinatel et al., Chromatin redistribution of the DEK oncoprotein represses hTERT transcription in leukemias, Neoplasia, vol.16, issue.1, p.3927101, 2014.

M. J. Gamble and R. P. Fisher, SET and PARP1 remove DEK from chromatin to permit access by the transcription machinery, Nature structural & molecular biology, vol.14, issue.6, pp.548-55, 2007.
DOI : 10.1038/nsmb1248

J. Sun, F. Bi, Y. Yang, Y. Zhang, J. A. Li et al., DEK protein overexpression predicts poor prognosis in pancreatic ductal adenocarcinoma, Oncology reports, vol.37, issue.2, p.27959420, 2017.
DOI : 10.3892/or.2016.5302

D. Lin, X. Dong, K. Wang, A. W. Wyatt, F. Crea et al., Identification of DEK as a potential therapeutic target for neuroendocrine prostate cancer, Oncotarget, vol.6, issue.3, p.4359333, 2015.

H. C. Yi, Y. L. Liu, P. You, J. S. Pan, J. Y. Zhou et al., Overexpression of DEK gene is correlated with poor prognosis in hepatocellular carcinoma, Molecular medicine reports, vol.11, issue.2, p.25351213, 2015.

L. Yu, X. Huang, W. Zhang, H. Zhao, G. Wu et al., Critical role of DEK and its regulation in tumorigenesis and metastasis of hepatocellular carcinoma, Oncotarget, vol.7, issue.18, p.5042019, 2016.

M. S. Khodadoust, M. Verhaegen, F. Kappes, E. Riveiro-falkenbach, J. C. Cigudosa et al., Melanoma proliferation and chemoresistance controlled by the DEK oncogene, Cancer Res, vol.69, 2009.
DOI : 10.1158/0008-5472.can-09-1063

URL : http://cancerres.aacrjournals.org/content/canres/69/16/6405.full.pdf

F. Kappes, M. S. Khodadoust, L. Yu, D. S. Kim, D. R. Fullen et al., DEK expression in melanocytic lesions, Human pathology, vol.42, issue.7, p.3162348, 2011.
DOI : 10.1016/j.humpath.2010.10.022

URL : http://europepmc.org/articles/pmc3162348?pdf=render

A. K. Adams, G. E. Hallenbeck, K. A. Casper, Y. J. Patil, K. M. Wilson et al., DEK promotes HPV-positive and-negative head and neck cancer cell proliferation, Oncogene, vol.34, issue.7, p.4160430, 2015.
DOI : 10.1038/onc.2014.15

URL : http://europepmc.org/articles/pmc4160430?pdf=render

E. A. Smith, B. Kumar, K. Komurov, S. M. Smith, N. V. Brown et al., DEK associates with tumor stage and outcome in HPV16 positive oropharyngeal squamous cell carcinoma, Oncotarget, vol.8, issue.14, p.28423581, 2017.
DOI : 10.18632/oncotarget.15582

URL : http://www.oncotarget.com/index.php?journal=oncotarget&page=article&op=download&path%5B%5D=15582&path%5B%5D=49774

L. J. Lin and L. T. Chen, The role of DEK protein in hepatocellular carcinoma for progression and prognosis, Pakistan journal of medical sciences, vol.29, issue.3, p.3809293, 2013.

L. Lin, J. Piao, W. Gao, Y. Piao, J. G. Ma et al., DEK over expression as an independent biomarker for poor prognosis in colorectal cancer, BMC Cancer, vol.13, 2013.
DOI : 10.1186/1471-2407-13-366

URL : https://bmccancer.biomedcentral.com/track/pdf/10.1186/1471-2407-13-366?site=bmccancer.biomedcentral.com

E. Riveiro-falkenbach, Y. Ruano, R. M. Garcia-martin, L. D. Cifdaloz, M. Acquadro et al., DEK oncogene is overexpressed during melanoma progression. Pigment cell & melanoma research, p.27893188, 2016.
DOI : 10.1111/pcmr.12563

U. Testa, G. Castelli, and E. Pelosi, Esophageal Cancer: Genomic and Molecular Characterization, Stem Cell Compartment and Clonal Evolution. Medicines, vol.4, issue.3, 2017.

A. Jemal, F. Bray, M. M. Center, J. Ferlay, E. Ward et al., Global cancer statistics, CA Cancer J Clin, vol.61, issue.2, p.21296855, 2011.

L. A. Torre, F. Bray, R. L. Siegel, J. Ferlay, J. Lortet-tieulent et al., Global cancer statistics, CA Cancer J Clin, vol.65, issue.2, p.25651787, 2012.
DOI : 10.3322/caac.21262

G. D. Stoner and A. Gupta, Etiology and chemoprevention of esophageal squamous cell carcinoma. Carcinogenesis, vol.22, 2001.

Z. Yang, B. Guan, T. Men, J. Fujimoto, and X. Xu, Comparable Molecular Alterations in 4-Nitroquinoline 1Oxide-induced Oral and Esophageal Cancer in Mice and in Human Esophageal Cancer, Associated with Poor Prognosis of Patients, vol.27, p.3849809, 2013.

E. B. Ludmir, S. J. Stephens, M. Palta, C. G. Willett, and B. G. Czito, Human papillomavirus tumor infection in esophageal squamous cell carcinoma, Journal of gastrointestinal oncology, vol.6, issue.3, p.4397257, 2015.

Y. H. Chen, H. I. Lu, C. Y. Chien, C. M. Lo, Y. M. Wang et al., Treatment Outcomes of Patients with Locally Advanced Synchronous Esophageal and Head/Neck Squamous Cell Carcinoma Receiving Curative Concurrent Chemoradiotherapy, Scientific reports, vol.7, p.5278381, 2017.
DOI : 10.1038/srep41785

URL : http://www.nature.com/articles/srep41785.pdf

Y. Song, L. Li, Y. Ou, Z. Gao, E. Li et al., Identification of genomic alterations in oesophageal squamous cell cancer, Nature, vol.509, issue.7498, p.24670651, 2014.
DOI : 10.1038/nature13176

Y. B. Gao, Z. L. Chen, J. G. Li, X. D. Hu, X. J. Shi et al., Genetic landscape of esophageal squamous cell carcinoma, Nature genetics, vol.46, issue.10, p.25151357, 2014.

D. C. Lin, J. J. Hao, Y. Nagata, L. Xu, L. Shang et al., Genomic and molecular characterization of esophageal squamous cell carcinoma, Nature genetics, vol.46, issue.5, p.4070589, 2014.

, Comprehensive genomic characterization of head and neck squamous cell carcinomas, Nature, vol.517, issue.7536, p.4311405, 2015.

J. Ringash, Survivorship and Quality of Life in Head and Neck Cancer, J Clin Oncol, 2015.

T. M. Wise-draper, H. V. Allen, M. N. Thobe, E. E. Jones, K. B. Habash et al., The human DEK protooncogene is a senescence inhibitor and an upregulated target of high-risk human papillomavirus E7, Epub 2005/10/29, vol.79, p.1280217, 2005.

T. M. Wise-draper, R. J. Morreale, T. A. Morris, R. A. Mintz-cole, E. E. Hoskins et al., DEK protooncogene expression interferes with the normal epithelial differentiation program, Am J Pathol, vol.174, issue.1, p.2631320, 2009.

T. M. Wise-draper, H. V. Allen, E. E. Jones, K. B. Habash, H. Matsuo et al., Apoptosis inhibition by the human DEK oncoprotein involves interference with p53 functions, Mol Cell Biol, vol.26, 2006.

K. Liu, T. Feng, J. Liu, M. Zhong, and S. Zhang, Silencing of the DEK gene induces apoptosis and senescence in CaSki cervical carcinoma cells via the up-regulation of NF-kappaB p65, Bioscience reports, vol.32, issue.3, 2012.

J. Richter, U. Wagner, P. Schraml, R. Maurer, G. Alund et al., Chromosomal imbalances are associated with a high risk of progression in early invasive (pT1) urinary bladder cancer, Cancer Res, vol.59, issue.22, pp.5687-91, 1999.

E. Prat, M. Bernues, M. R. Caballin, J. Egozcue, A. Gelabert et al., Detection of chromosomal imbalances in papillary bladder tumors by comparative genomic hybridization, Urology, vol.57, issue.5, pp.986-92, 2001.

S. Selvarajah, M. Yoshimoto, O. Ludkovski, P. C. Park, J. Bayani et al., Genomic signatures of chromosomal instability and osteosarcoma progression detected by high resolution array CGH and interphase FISH. Cytogenetic and genome research, vol.122, pp.5-15, 2008.

J. Bruch, W. A. Schulz, J. Haussler, I. Melzner, S. Bruderlein et al., Delineation of the 6p22 amplification unit in urinary bladder carcinoma cell lines, Cancer Res, vol.60, issue.16, 2000.

D. Chen, S. Pajovic, A. Duckett, V. D. Brown, J. A. Squire et al., Genomic amplification in retinoblastoma narrowed to 0.6 megabase on chromosome 6p containing a kinesin-like gene, RBKIN. Cancer Res, vol.62, issue.4, pp.967-71, 2002.

F. Andre, P. Dessen, J. B. Delaloge, S. Pusztai, L. Lazar et al., Functional pathways analyses to identify candidate therapeutic targets in triple-negative breast cancer, J Clin Oncol (Meeting Abstracts), vol.27, issue.15S, p.569, 2009.

R. Babaei-jadidi, N. Li, A. Saadeddin, B. Spencer-dene, A. Jandke et al., FBXW7 influences murine intestinal homeostasis and cancer, targeting Notch, Jun, and DEK for degradation. The Journal of experimental medicine, vol.208, p.3039859, 2011.

F. Y. Lo, J. W. Chang, I. S. Chang, Y. J. Chen, H. S. Hsu et al., The database of chromosome imbalance regions and genes resided in lung cancer from Asian and Caucasian identified by array-comparative genomic hybridization, BMC Cancer, vol.12, p.3488578, 2012.

X. Li, W. Zhang, L. Zhou, D. Yue, and X. Su, MicroRNA-592 targets DEK oncogene and suppresses cell growth in the hepatocellular carcinoma cell line HepG2, International journal of clinical and experimental pathology, vol.8, issue.10, p.4680377, 2015.

J. P. Theurillat, N. D. Udeshi, W. J. Errington, T. Svinkina, S. C. Baca et al., Prostate cancer. Ubiquitylome analysis identifies dysregulation of effector substrates in SPOP-mutant prostate cancer, Science, vol.346, issue.6205, p.25278611, 2014.

P. Central and P. , , p.4257137

X. Wu, G. Wu, Z. Wu, X. Yao, and G. Li, MiR-200a Suppresses the Proliferation and Metastasis in Pancreatic Ductal Adenocarcinoma through Downregulation of DEK Gene, Transl Oncol, vol.9, issue.1, p.4800058, 2016.

P. Vinnedge, L. M. Ho, S. Wikenheiser-brokamp, K. A. Wells, and S. I. , The DEK Oncogene Is a Target of Steroid Hormone Receptor Signaling in Breast Cancer, PloS one, vol.7, issue.10, p.23071688, 2012.

T. Nakashima, H. Tomita, A. Hirata, K. Ishida, K. Hisamatsu et al., Promotion of cell proliferation by the proto-oncogene DEK enhances oral squamous cell carcinogenesis through field cancerization. Cancer medicine, p.28834425, 2017.

X. H. Tang, B. Knudsen, D. Bemis, S. Tickoo, and L. J. Gudas, Oral cavity and esophageal carcinogenesis modeled in carcinogen-treated mice, Clin Cancer Res, vol.10, issue.1, pp.301-314, 2004.

K. Osei-sarfo, A. M. Urvalek, X. H. Tang, T. Scognamiglio, and L. J. Gudas, Initiation of esophageal squamous cell carcinoma (ESCC) in a murine 4-nitroquinoline-1-oxide and alcohol carcinogenesis model, Oncotarget, vol.6, issue.8, p.25714027, 2015.

P. Central and P. , , p.4467420

L. Vitale-cross, R. Czerninski, P. Amornphimoltham, V. Patel, A. A. Molinolo et al., Chemical carcinogenesis models for evaluating molecular-targeted prevention and treatment of oral cancer. Cancer prevention research, vol.2, pp.419-441, 2009.

S. F. Jabbar, L. Abrams, A. Glick, and P. F. Lambert, Persistence of high-grade cervical dysplasia and cervical cancer requires the continuous expression of the human papillomavirus type 16 E7 oncogene, Cancer Res, vol.69, issue.10, p.3006677, 2009.

P. Vinnedge, L. M. Mcclaine, R. Wagh, P. K. Wikenheiser-brokamp, K. A. Waltz et al., The human DEK oncogene stimulates beta-catenin signaling, invasion and mammosphere formation in breast cancer, Oncogene, vol.30, issue.24, p.3117026, 2011.

M. C. Matrka, M. Watanabe, R. Muraleedharan, P. F. Lambert, A. N. Lane et al., Overexpression of the human DEK oncogene reprograms cellular metabolism and promotes glycolysis, PloS one, vol.12, issue.5, p.28558019, 2017.

M. C. Matrka, R. F. Hennigan, F. Kappes, M. L. Delay, P. F. Lambert et al., DEK over-expression promotes mitotic defects and micronucleus formation, Cell Cycle, vol.14, issue.24, p.4825741, 2015.

J. Martinez-useros, M. Rodriguez-remirez, A. Borrero-palacios, I. Moreno, A. Cebrian et al., DEK is a potential marker for aggressive phenotype and irinotecan-based therapy response in metastatic colorectal cancer, BMC Cancer, vol.14, p.4300837, 2014.

A. Datta, M. E. Adelson, Y. Mogilevkin, E. Mordechai, A. A. Sidi et al., Oncoprotein DEK as a tissue and urinary biomarker for bladder cancer, BMC Cancer, vol.11, 2011.

J. Stenman, H. Toresson, and K. Campbell, Identification of two distinct progenitor populations in the lateral ganglionic eminence: implications for striatal and olfactory bulb neurogenesis. The Journal of neuroscience: the official journal of the Society for Neuroscience, vol.23, pp.167-74, 2003.

S. Jabbar, K. Strati, M. K. Shin, H. C. Pitot, and P. F. Lambert, Human papillomavirus type 16 E6 and E7 oncoproteins act synergistically to cause head and neck cancer in mice, Virology, vol.407, issue.1, p.2946459, 2010.

K. Strati, H. C. Pitot, and P. F. Lambert, Identification of biomarkers that distinguish human papillomavirus (HPV)-positive versus HPV-negative head and neck cancers in a mouse model, Proc Natl Acad Sci, vol.103, issue.38, p.1599927, 2006.

A. Gunji, A. Uemura, M. Tsutsumi, T. Nozaki, O. Kusuoka et al., Parp-1 deficiency does not increase the frequency of tumors in the oral cavity and esophagus of ICR/129Sv mice by 4-nitroquinoline 1-oxide, a carcinogen producing bulky adducts, Cancer Lett, vol.241, issue.1, p.16338061, 2005.

J. Wang, L. Sun, M. Yang, W. Luo, Y. Gao et al., DEK depletion negatively regulates Rho/ROCK/ MLC pathway in non-small cell lung cancer. The journal of histochemistry and cytochemistry: official journal of the Histochemistry Society, vol.61, 2013.
DOI : 10.1369/0022155413488120

URL : http://journals.sagepub.com/doi/pdf/10.1369/0022155413488120

S. Waidmann, B. Kusenda, J. Mayerhofer, K. Mechtler, and C. Jonak, A DEK domain-containing protein modulates chromatin structure and function in Arabidopsis. The Plant cell, vol.26, p.4277211, 2014.
DOI : 10.1105/tpc.114.129254

URL : http://www.plantcell.org/content/26/11/4328.full.pdf

K. S. Lee, D. W. Kim, J. Y. Kim, J. K. Choo, K. Yu et al., Caspase-dependent apoptosis induction by targeted expression of DEK in Drosophila involves histone acetylation inhibition, Journal of cellular biochemistry, vol.103, issue.4, p.17685435, 2008.
DOI : 10.1002/jcb.21511

M. D. Abramoff, P. J. Magalhaes, and S. J. Ram, Image Processing with ImageJ, Biophotonics International, vol.11, issue.7, pp.36-42, 2004.

I. Diamond, T. Owolabi, M. Marco, C. Lam, and A. Glick, Conditional Gene Expression in the Epidermis of Transgenic Mice Using the Tetracycline-Regulated Transactivators tTA and rTA Linked to the Keratin 5

. Promoter, Journal of Investigative Dermatology, vol.115, issue.5, p.11069615

T. Tumbar, G. Guasch, V. Greco, C. Blanpain, W. E. Lowry et al., Defining the Epithelial Stem Cell Niche in Skin, Science, vol.303, issue.5656, p.2405920, 2004.

J. A. Nowak and E. Fuchs, Isolation and Culture of Epithelial Stem Cells, Methods in molecular biology (Clifton, vol.482, p.2760227, 2009.

J. Jones, Isolation and Culture of Mouse Keratinocytes, Cold Spring Harbor Protocols, issue.7, 2008.